Companies › NBIX

NEUROCRINE BIOSCIENCES INC (NBIX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000914475 · EDGAR filings · Updated 2026-07-27

NEUROCRINE BIOSCIENCES INC (NBIX) has reported institutional ownership of 99.0%, with 689 institutional managers holding positions valued at $13.1B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-10 — Notice of proposed sale filed (Form 144)
• 2026-07-09 — Insider transaction reported (Form 4)
• 2026-07-09 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEUROCRINE BIOSCIENCES INC has 689 institutional holders and institutional ownership of 99.0%.

Insider activity

Insiders reported 139 transactions (0 buys, 16 sells) across 19 reporting insiders, with a net reported value of −$43.0M.

Related companies

INSULET CORP (PODD) · BRIDGEBIO PHARMA INC (BBIO) · VIATRIS INC (VTRS) · ELANCO ANIMAL HEALTH INC (ELAN) · IONIS PHARMACEUTICALS INC (IONS) · GUARDANT HEALTH INC (GH)